|
|||||||
|
Multiple Sclerosis Info
|
Tuesday, February 26
Study - Clustering of autoimmune diseases in families with a high-risk for MS
by
multiplesclerosis
on Tue 26 Feb 2008 09:02 AM CST
Autoimmune mechanisms are thought to have a major role in the pathogenesis of multiple sclerosis. We aimed to identify coexisting autoimmune phenotypes in patients with multiple sclerosis from families with several members with the disease and more »
Video - Goals of MS Therapy
by
multiplesclerosis
on Tue 26 Feb 2008 08:31 AM CST
Video
These goals apply to all four MS Injectable Therapies, including Copaxone, not just the interferon therapies. more »
study - Copaxone - reduced the risk of developing clinically definite MS
by
multiplesclerosis
on Tue 26 Feb 2008 07:33 AM CST
The results showed that treatment with COPAXONE® (glatiramer acetate injection) reduced the risk of developing clinically definite MS (CDMS) by 44 percent versus placebo, and more »
Predictive markers for response to interferon therapy in patients with multiple sclerosis.
by
multiplesclerosis
on Tue 26 Feb 2008 12:00 AM CST
Prolonged therapy with interferon beta (IFNbeta) often leads to the development of anti-IFNbeta binding antibodies (BAbs). A subset of the BAbs is of a neutralizing nature (neutralizing antibodies, NAbs) and more »
How Your Digestive System Works 4 or 4
by
multiplesclerosis
on Tue 26 Feb 2008 12:00 AM CST
As this residue passes through the colon, nearly all of the water is absorbed, leaving a usually soft but formed substance called stool. Muscles in the wall of your colon more »
|
||||||
